These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8049432

  • 1. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA, Schapira M.
    Blood; 1994 Aug 15; 84(4):1164-72. PubMed ID: 8049432
    [Abstract] [Full Text] [Related]

  • 2. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R, Umemura K, Hashimmoto H, Urano T.
    Thromb Haemost; 2006 Apr 15; 95(4):637-42. PubMed ID: 16601834
    [Abstract] [Full Text] [Related]

  • 3. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.
    Audenaert AM, Knockaert I, Collen D, Declerck PJ.
    J Biol Chem; 1994 Jul 29; 269(30):19559-64. PubMed ID: 8034724
    [Abstract] [Full Text] [Related]

  • 4. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1.
    Gebbink RK, Reynolds CH, Tollefsen DM, Mertens K, Pannekoek H.
    Biochemistry; 1993 Feb 16; 32(6):1675-80. PubMed ID: 8431448
    [Abstract] [Full Text] [Related]

  • 5. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

  • 6. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.
    van Meijer M, Smilde A, Tans G, Nesheim ME, Pannekoek H, Horrevoets AJ.
    Blood; 1997 Sep 01; 90(5):1874-82. PubMed ID: 9292520
    [Abstract] [Full Text] [Related]

  • 7. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR.
    Biochemistry; 1999 Nov 02; 38(44):14592-9. PubMed ID: 10545182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M, Stoop A, Smilde A, Preissner KT, van Zonneveld AJ, Pannekoek H.
    Thromb Haemost; 1997 Mar 02; 77(3):516-21. PubMed ID: 9066004
    [Abstract] [Full Text] [Related]

  • 10. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M, Roelofs Y, Neels J, Horrevoets AJ, van Zonneveld AJ, Pannekoek H.
    J Biol Chem; 1996 Mar 29; 271(13):7423-8. PubMed ID: 8631768
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S, Lawrence DA, Argraves WS.
    J Biol Chem; 1996 Apr 05; 271(14):8215-20. PubMed ID: 8626514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin.
    Urano T, Ihara H, Takada Y, Nagai N, Takada A.
    Biochim Biophys Acta; 1996 Dec 05; 1298(2):199-208. PubMed ID: 8980646
    [Abstract] [Full Text] [Related]

  • 14. Heparin and heparan sulfate enhancement of the inhibitory activity of plasminogen activator inhibitor type 1 toward urokinase type plasminogen activator.
    Urano T, Serizawa K, Takada Y, Ny T, Takada A.
    Biochim Biophys Acta; 1994 Nov 11; 1201(2):217-22. PubMed ID: 7947934
    [Abstract] [Full Text] [Related]

  • 15. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
    Keijer J, Linders M, Wegman JJ, Ehrlich HJ, Mertens K, Pannekoek H.
    Blood; 1991 Sep 01; 78(5):1254-61. PubMed ID: 1715220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ, Gebbink RK, Keijer J, Linders M, Preissner KT, Pannekoek H.
    J Biol Chem; 1990 Aug 05; 265(22):13029-35. PubMed ID: 1695900
    [Abstract] [Full Text] [Related]

  • 18. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L, Martensen PM, Sottrup-Jensen L, Justesen J, Rodenburg KW, Andreasen PA.
    Eur J Biochem; 1996 Oct 01; 241(1):38-46. PubMed ID: 8898886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.